Mologen (Germany)

Recent papers from Mologen (Germany)

1. Statistics and Ontology of Published Small Molecule Ring Systems.2026
2. Inhibition of acyl‐ACP thioesterase as site of action of the commercial herbicides cumyluron, oxaziclomefone, bromobutide, methyldymron and tebutamPest Management Science · 2022
3. Rapid high-resolution structure analysis of small, biotechnologically relevant enzymes by cryo-electron microscopy2021
4. Metabolic Profiling of Borrelia in Ticks and in Whole Blood Samples by Headspace Gas Chromatography - A Case ReportAmerican Journal of Biomedical Science & Research · 2019
5. Beneficial modulation of the tumor microenvironment and generation of anti-tumor responses by TLR9 agonist lefitolimod alone and in combination with checkpoint inhibitorsOncoImmunology · 2019
6. TLR9 agonist MGN1703 enhances B cell differentiation and function in lymph nodesEBioMedicine · 2019
7. Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemiaHaematologica · 2019
8. Effects of 24-week Toll-like receptor 9 agonist treatment in HIV type 1+ individualsAIDS · 2019
9. EnanDIM - a novel family of L-nucleotide-protected TLR9 agonists for cancer immunotherapyJournal for ImmunoTherapy of Cancer · 2019
10. Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE studyAnnals of Oncology · 2018
11. Distinct immunological activation profiles of dSLIM® and ProMune® depend on their different structural contextImmunity Inflammation and Disease · 2016
12. Design and characterization of the tumor vaccine MGN1601, allogeneic fourfold gene-modified vaccine cells combined with a TLR-9 agonistMolecular Therapy — Oncolytics · 2016
13. Immune response of healthy horses to DNA constructs formulated with a cationic lipid transfection reagentBMC Veterinary Research · 2015
14. Local and systemic effect of transfection-reagent formulated DNA vectors on equine melanomaBMC Veterinary Research · 2015
15. Local and systemic effect of transfection-reagent formulated DNA vectors on equine melanomaBMC Veterinary Research · 2015
16. Design and Structural Requirements of the Potent and Safe TLR-9 Agonistic Immunomodulator MGN1703Nucleic Acid Therapeutics · 2015
17. MGN1703, an immunomodulator and toll-like receptor 9 (TLR-9) agonist: From bench to bedsideCritical Reviews in Oncology/Hematology · 2014
18. Cationic Lipid-Formulated DNA Vaccine against Hepatitis B Virus: Immunogenicity of MIDGE-Th1 Vectors Encoding Small and Large Surface Antigen in Comparison to a Licensed Protein VaccinePLoS ONE · 2014
19. Modular Multiantigen T Cell Epitope–Enriched DNA Vaccine Against Human LeishmaniasisScience Translational Medicine · 2014
20. Preclinical study on combined chemo‐ and nonviral gene therapy for sensitization of melanoma using a human TNF‐alpha expressing MIDGE DNA vectorMolecular Oncology · 2014